👀 Ones to watch: Undervalued stocks to buy before they report Q3 earningsSee Undervalued Stocks

Microsoft launches AI tools for healthcare sector

Published 10/10/2024, 16:06
© Reuters.
MSFT
-

REDMOND, Wash. - Microsoft Corp (NASDAQ:MSFT). announced new artificial intelligence (AI) innovations within its Microsoft Cloud for Healthcare, aiming to improve care experiences, enhance collaboration among healthcare teams, and provide better operational and clinical insights.

The company introduced healthcare AI models in Azure AI Studio, developed in partnership with entities such as Providence and Paige.ai. These models are designed to assist healthcare organizations in analyzing various data types, including medical imaging and clinical records, to expedite the building and deployment of tailored AI solutions.

In addition to these AI models, Microsoft announced the general availability of healthcare data solutions in Microsoft Fabric, which provides a unified AI-powered platform to manage and utilize healthcare data. This includes conversational data integration and social determinants of health public dataset transformation, among other capabilities.

Furthermore, Microsoft unveiled a public preview of the healthcare agent service in Copilot Studio. This service allows the creation of Copilot agents for tasks such as appointment scheduling and patient triaging. The Cleveland Clinic is among the early adopters using these innovations to improve patient experiences and operational efficiency.

Microsoft also highlighted its AI-driven nursing workflow solution, which was developed in collaboration with healthcare organizations like Advocate Health and Duke Health. The technology aims to alleviate the administrative burden on nurses, allowing them to focus more on patient care.

According to Joe Petro, corporate vice president at Microsoft, these advancements are enhancing patient care and the practice of medicine. The company is dedicated to responsible AI development, adhering to principles established in 2018 to ensure positive impacts on healthcare and society.

The new AI solutions and their potential effects on the healthcare industry were presented at HLTH 2024, with more information available on Microsoft's website. This press release statement from Microsoft Corp. underlines the company's commitment to advancing AI in healthcare while maintaining responsible practices.

In other recent news, the S&P 500 earnings spotlight has turned to tech and AI growth, with companies like Microsoft and Rezolve AI making significant strides. The technology sector's earnings are estimated to have increased by 15.4%, and communication services are projected to have risen by 12.3% compared to last year's quarter. Major AI-centric companies have been at the forefront of these earnings.

One of the key players, Microsoft, has seen a price target adjustment by Goldman Sachs (NYSE:GS) due to increased capital expenditure estimates for AI developments. However, the firm maintains a positive outlook, projecting a 14% revenue growth for Microsoft.

Simultaneously, Microsoft is forming strategic partnerships. A notable alliance is with Rezolve AI, aiming to revolutionize the global retail industry with advanced AI solutions. This partnership is expected to aid Rezolve AI in surpassing $100 million in annual recurring revenue by 2025.

However, analyst firm Oppenheimer has downgraded Microsoft's stock due to concerns over higher-than-expected losses from its OpenAI investment and slower enterprise adoption of AI technology. On the contrary, Truist Securities has reiterated a Buy rating for Microsoft, emphasizing the company's strength in the cybersecurity sector.

These recent developments underscore the dynamic nature of the tech and AI sectors, with companies like Microsoft and Rezolve AI pushing boundaries and capturing investor attention.

InvestingPro Insights

Microsoft's recent announcement of AI innovations in healthcare aligns with its strong market position and financial performance. According to InvestingPro data, Microsoft boasts a substantial market capitalization of $3.08 trillion, reflecting its dominant presence in the tech industry. The company's revenue growth of 15.67% over the last twelve months demonstrates its ability to capitalize on emerging technologies like AI.

InvestingPro Tips highlight Microsoft's status as a "prominent player in the Software industry," which is evident in its healthcare AI initiatives. The company's strong financial position is further underscored by its ability to maintain dividend payments for 22 consecutive years, with a current dividend yield of 0.8%.

Microsoft's focus on AI-driven solutions in healthcare is likely to contribute to its future growth prospects. With a high return over the last decade and a strong return over the last five years, as noted in the InvestingPro Tips, Microsoft continues to demonstrate its capacity for innovation and market leadership.

For investors interested in a deeper analysis of Microsoft's financial health and growth potential, InvestingPro offers 14 additional tips, providing a comprehensive view of the company's prospects in the evolving tech landscape.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.